RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

Overview of attention for article published in JAMA: Journal of the American Medical Association, October 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 113 news outlets
blogs: 6 blogs
twitter: 71 X users
facebook: 2 Facebook pages

video: 1 YouTube creator
guideline: 1 clinical guideline source
bluesky: 22 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 80 X posts from 71 X users, with an upper bound of 1,902,715 followers.

RSV vaccines cut hospitalization risk by 58% in older adults, but effectiveness dips for the immunocompromised and those with heart disease. by Surie D, Self WH (...) Dawood FS et 46 al. in JAMA https://t.co/S9XRgyZD7K #MedX #MedResearch

Eficacia de la vacuna contra el VSR contra la hospitalización entre adultos estadounidenses de 60 años o más durante dos temporadas https://t.co/f9EEiHMFG9

RT @KaminskiMed: Respiratory syncytial virus vaccines prevented RSV-associated hospitalization during 2 seasons #VaccinesWork #ScienceMatt…

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. https://t.co/Bixs1IwJei

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 76 additional X posts.